Menu
Skip to content

Advanced DWI and Oncologic Imaging

Advanced DWI and Oncologic Imaging

The research group has a long tradition since 1997. Conventional DWI is an established tool in oncologic imaging for detecting tumors through their altered local apparent water diffusion without the use of contrast agents. Advanced DWI techniques as computed DWI (cDWI) and diffusion-weighted whole body MRI (DWIBS) improve lesion detectebility. Intravoxel incoherent motion (IVIM) analysis yields additional information about microcirculation, which is helpful for lesion characterization. Our aim is to optimize and validate these advanced thechniques for the use in clinical routine diagnostic imaging.

„Simplified“ IVIM (Intravoxel incoherent motion)

for tumors of the liver, pancreas, breast and spine

  • Evaluation of lesion detection and characterization
  • Optimization of technique and clinical validation
  • Colormaps to facilitate visual image analysis
  • Outcome prediction
  • Investigation of measurement reproducibility
  • Measurement sequence optimization

cDWI (computed DWI)

for prostate imaging

  • Evaluation of lesion detection and characterization

DWIBS (Diffusion-weighted whole-body MRI)

for thoracic malignancies and neurography

  • Evaluation of lesion detection and characterization
  • Visualization of the brachial and lumbosacral plexus

Group Leader

PD Dr. med. Claus C. Pieper
Tel.: +49 228 287 16534
E-Mail: Enable JavaScript to view protected content.
Publications

Dr. rer. nat. Petra Mürtz
Tel.: +49 228 287 14496, 15960
E-Mail: Enable JavaScript to view protected content.
Publications
Scientific career

Members / Partners

Dr. Alois M. Sprinkart (Core Facility)
Dr. Patrick A. Kupczyk
Dr. Carsten Schmeel
PD Dr. Wolfgang Block
Dr. Roy König
Narine Mesropyan
Michael Reick (doctoral candidate)
Darius Kurt (doctoral candidate)

Unsere Webseite verwendet Cookies.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

Unsere Webseite verwendet Cookies.

These include essential cookies that are necessary for the operation of the site, as well as others that are used only for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, not all functions of the website may be available.

Your cookie preferences have been saved.

Information gemäß § 6 Medizinprodukte-Betreiberverordnung "Beauftragter für Medizinproduktesicherheit"

Sehr geehrte Damen und Herren,

gemäß § 6 Medizinprodukte-Betreiberverordnung steht Ihnen das Universitätsklinikum Bonn im Zusammenhang mit Meldungen über Risiken von Medizinprodukten, Informationen zu Rückrufen oder Warn- und Sicherheitshinweisen sowie bei der Umsetzung von notwendigen korrektiven Maßnahmen unter folgender E-Mailadresse zur Verfügung: Enable JavaScript to view protected content.

Diese E-Mailadresse richtet sich vorzugsweise an Kontaktpersonen von Behörden, Herstellern und Vertreibern von Medizinprodukten.